company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32726000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32726000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3630000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3630000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29096000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4463000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6022000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3143000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,5254000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18882000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10214000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,259000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,664000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11501000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11906000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22120000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10473000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11647000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11647000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11647000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40207000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.29
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42879000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40200000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:53:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.29
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48602000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48602000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2756000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2756000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45846000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5873000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7204000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3139000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,32000000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48216000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2370000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2726000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,310000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3565000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5981000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8351000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8507000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16858000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16858000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16858000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40353000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.42
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40353000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.42
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39200000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q2,2015-04-01,2015-06-30,2016-08-12 18:46:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,47313000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,47313000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2087000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2087000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,45226000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4568000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7221000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3141000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,44782000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59712000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14486000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6644000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,197000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,160000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6287000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20773000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7302000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28075000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28075000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28075000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40625000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.69
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40625000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.69
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38500000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q3,2015-07-01,2015-09-30,2016-11-14 16:44:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.73
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44368000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44368000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2937000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2937000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41431000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6808000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5161000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3141000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-51079000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-35969000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,77400000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-9629000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,65000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2385000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7309000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,84709000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9625000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,75084000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,75084000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,75084000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40580000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.85
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43619000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.8
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40600000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.9
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36216000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36216000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3906000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3906000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32310000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9461000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5388000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3514000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,8243000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26606000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5704000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,175000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,200000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4475000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4450000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1254000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7312000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6058000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6058000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6058000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41241000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41241000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40400000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 17:25:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38858000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38858000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3907000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3907000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34951000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11290000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7604000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3702000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,23898000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46494000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11543000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,263000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,390000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1093000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-966000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12509000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7449000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19958000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19958000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19958000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41241000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41241000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41600000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 17:06:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32087000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32087000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2844000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2844000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29243000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12740000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8143000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3702000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,20848000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,45433000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16190000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,264000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,490000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-579000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-353000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16543000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3451000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19994000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19994000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19994000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41241000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41241000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41700000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 14:58:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,43085000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,43085000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2591000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2591000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40494000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10688000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13476000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2970000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-3704000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23430000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,17064000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,261000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1678000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-401000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1016000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18080000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13346000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4734000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4734000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4734000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41248000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41248000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41300000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,52507000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,52507000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3902000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3902000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,48605000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11812000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7206000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,564000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-4318000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15264000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,33341000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,263000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,821000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,550000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1108000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,34449000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8539000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,25910000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,25910000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,25910000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41374000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42810000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41100000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q1,2017-01-01,2017-03-31,2018-05-04 13:07:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,46311000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,46311000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4561000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4561000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41750000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12429000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6792000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,564000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-12161000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7624000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,34126000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,263000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,764000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1670000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2171000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,36297000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7370000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28927000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,28927000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,28927000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41091000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.7
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42487000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.68
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41300000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 17:08:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.7
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39675000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39675000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3790000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3790000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35885000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11563000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8095000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,564000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-10455000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9767000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26118000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,263000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,977000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,768000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1482000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,27600000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5921000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,21679000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,21679000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,21679000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40061000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.54
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41339000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40100000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q3,2017-07-01,2017-09-30,2018-11-05 17:03:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.54
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34752000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34752000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4048000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4048000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30704000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23056000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11325000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1967000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-1564000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34784000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4080000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,263000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-426000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-917000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1606000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5686000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2559000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8245000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8245000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8245000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40465000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.18
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41765000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.18
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40400000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.18
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33293000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33293000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6592000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6592000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26701000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24487000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9951000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1767000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3121000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39326000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12625000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1597000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,54000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-395000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1938000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14563000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2327000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12236000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12236000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12236000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,38559000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38559000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38200000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:59:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29230000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29230000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3512000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3512000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25718000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27843000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11890000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1609000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-12839000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28503000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-2785000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2980000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,583000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1402000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-995000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3780000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-342000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3438000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3438000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3438000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36772000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36772000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,38200000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 13:07:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19826000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19826000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3120000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3120000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16706000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,24829000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11402000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1620000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-7050000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30801000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14095000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3000000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,208000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,425000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2367000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16462000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-691000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15771000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15771000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15771000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36904000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36904000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36700000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 15:59:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20920000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20920000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4292000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4292000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16628000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23200000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6086000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1623000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,66087000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-4947000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,92049000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-75421000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3045000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-393000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,467000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2971000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-78392000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-14533000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-63859000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-63859000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-63859000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37325000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.71
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37325000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.71
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37400000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.71
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16437000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16437000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3266000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3266000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13171000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10446000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7329000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,201000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,3362000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21338000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8167000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3062000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1856000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-307000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5225000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13392000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-374000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13018000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13018000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13018000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37354000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37354000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37200000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:32:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17554000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17554000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3622000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3622000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13932000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6758000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10292000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,204000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1129000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18383000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4451000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3106000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,783000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-50000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2373000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6824000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1781000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8605000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8605000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8605000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37356000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37356000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37400000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 13:07:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14229000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14229000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2823000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2823000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11406000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5316000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7539000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,205000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,2493000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15553000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4147000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3125000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,781000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-139000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2483000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6630000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2234000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8864000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8864000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8864000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37436000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37436000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36900000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 15:59:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10995000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10995000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2414000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2414000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8581000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7663000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7757000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,206000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,302000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15928000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7347000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3190000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1317000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,118000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4389000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11736000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-8997000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2739000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2739000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2739000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,37403000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,37403000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37300000.0
Avadel Pharmaceuticals PLC,AVDL,,0001012477,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
